Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Standard
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. / Rajkumar, S Vincent; Harousseau, Jean-Luc; Durie, Brian; Anderson, Kenneth C; Dimopoulos, Meletios; Kyle, Robert; Blade, Joan; Richardson, Paul; Orlowski, Robert; Siegel, David; Jagannath, Sundar; Facon, Thierry; Avet-Loiseau, Hervé; Lonial, Sagar; Palumbo, Antonio; Zonder, Jeffrey; Ludwig, Heinz; Vesole, David; Sezer, Orhan; Munshi, Nikhil C; Jesus, San Miguel.
in: BLOOD, Jahrgang 117, Nr. 18, 18, 2011, S. 4691-4695.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
AU - Rajkumar, S Vincent
AU - Harousseau, Jean-Luc
AU - Durie, Brian
AU - Anderson, Kenneth C
AU - Dimopoulos, Meletios
AU - Kyle, Robert
AU - Blade, Joan
AU - Richardson, Paul
AU - Orlowski, Robert
AU - Siegel, David
AU - Jagannath, Sundar
AU - Facon, Thierry
AU - Avet-Loiseau, Hervé
AU - Lonial, Sagar
AU - Palumbo, Antonio
AU - Zonder, Jeffrey
AU - Ludwig, Heinz
AU - Vesole, David
AU - Sezer, Orhan
AU - Munshi, Nikhil C
AU - Jesus, San Miguel
PY - 2011
Y1 - 2011
N2 - It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.
AB - It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.
KW - Humans
KW - Treatment Outcome
KW - Recurrence
KW - Clinical Trials, Phase III as Topic
KW - Clinical Trials as Topic
KW - Multiple Myeloma/therapy
KW - Humans
KW - Treatment Outcome
KW - Recurrence
KW - Clinical Trials, Phase III as Topic
KW - Clinical Trials as Topic
KW - Multiple Myeloma/therapy
M3 - SCORING: Journal article
VL - 117
SP - 4691
EP - 4695
JO - BLOOD
JF - BLOOD
SN - 0006-4971
IS - 18
M1 - 18
ER -